Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models

Title
Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models
Authors
Keywords
Akt inhibitor, Apoptosis, Enzalutamide, Prostate cancer
Journal
EUROPEAN UROLOGY
Volume 67, Issue 6, Pages 986-990
Publisher
Elsevier BV
Online
2014-08-21
DOI
10.1016/j.eururo.2014.08.006

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now